Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

<i>In Situ</i> Temperature-Dependent Properties of Metal-Organic Framework ZIF-Coated ZnO Hybrid Structures: Structural and Advanced Spectroscopic Insights.

ACS omega·2026
Same author

3D Aerohydrogel Scaffolds for Brain Tissue Engineering and <i>In Vitro</i> Neuroscience.

Chem & bio engineering·2026
Same author

High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors.

ACS medicinal chemistry letters·2026
Same author

Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's disease.

IBRO neuroscience reports·2025
Same author

Origami-inspired reprogrammable microactuator system.

Microsystems & nanoengineering·2025
Same author

Fluid dynamics model of the cerebral ventricular system.

Proceedings of the National Academy of Sciences of the United States of America·2025

相关实验视频

Updated: Jun 9, 2026

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration
08:52

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

14.8K

向质痕:生物材料和基于药物的在体外调节策略.

Luise Schlotterose1,2, Duygu Dengiz3, Meryem G Ersahin3

  • 1Institute of Anatomy, Kiel University, Kiel, Germany.

Journal of biomedical materials research. Part B, Applied biomaterials
|November 29, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种体外模型,用于测试用于中枢神经系统再生的药物和生物材料. 该平台评估了质痕的形成,有助于开发治疗方法和神经植入物.

关键词:
状痕是状痕的一种.材料与细胞的相互作用.尼丁醇是一种尼丁醇.形状记忆合金的合金表面的能量和粗度.转变的增长因子-ββ.

更多相关视频

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.5K
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.7K

相关实验视频

Last Updated: Jun 9, 2026

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration
08:52

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

14.8K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.5K
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.7K

科学领域:

  • 神经科学是一个神经科学.
  • 生物材料科学 生物材料科学
  • 再生医学是一种再生医学.

背景情况:

  • 质痕阻碍了中枢神经系统 (CNS) 受伤后的轴突再生和神经微电极发育.
  • 质性痕的关键特征包括加勒-3的表达和细胞外基质的积累.
  • 目前的方法缺乏有效的临床前评估治疗药物和生物材料用于中枢神经系统修复.

研究的目的:

  • 建立基于人类细胞系的体外模型,用于评估针对质痕形成的治疗药物和生物材料.
  • 证明该模型在评估药物标时的有用性,特别是转化增长因子-β受体I和II类型.
  • 通过研究细胞对植入物质在细胞物质接口上的细胞反应来整合生物材料科学.

主要方法:

  • 开发了一种基于人类细胞系的体外模型,模仿质痕特征.
  • 利用协同刺激系统和化学制造技术来研究细胞物质相互作用.
  • 评估了尼丁醇,黄金和表面对质痕相关基因表达的影响.

主要成果:

  • 在体外模型成功复制了关键的质痕特征.
  • 该模型通过调节TGF-β受体,验证了降低质痕形成的药物标.
  • 研究了各种植入物材料 (尼提诺,金,) 对质痕基因表达的影响.

结论:

  • 开发的平台加速了候选药物的验证和神经植入物材料的优化.
  • 这种方法有助于通过减轻质痕,制定中枢神经系统再生策略.
  • 综合系统支持治疗开发和神经工程的进步.